1. Trang chủ
  2. » Thể loại khác

Ebook Drug and device selection in heart failure: Part 1

125 48 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 125
Dung lượng 8,06 MB

Nội dung

(BQ) Part 1 book Drug and device selection in heart failure presents the following contents: Renewed understanding of the pathophysiology of heart failure, new diuretics in heart failure, emerging role of aldosterone receptor blockers in heart failure, traditional mechanical support,...

Drug and Device Selection in Heart Failure Drug and Device Selection in Heart Failure Editors Prakash C Deedwania MD FACC FACP FASH FAHA Professor of Medicine and Chief, Division of Cardiology Department of Medicine Veterans Affairs Central California Health Care System University of California, San Francisco Fresno, CA, USA Paul J Mather MD FACC FACP Professor of Medicine Director, Advanced Heart Failure and Cardiac Transplant Center Jefferson Heart Institute, Jefferson Medical College, Thomas Jefferson University Philadelphia, PA, USA Foreword Marvin A Konstam Jaypee Brothers Medical Publishers (P) Ltd New Delhi • London • Philadelphia • Panama Jaypee Brothers Medical Publishers (P) Ltd Headquarters Jaypee Brothers Medical Publishers (P) Ltd 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: jaypee@jaypeebrothers.com Overseas Offices J.P Medical Ltd 83, Victoria Street, London SW1H 0HW (UK) Phone: +44-2031708910 Fax: +02-03-0086180 Email: info@jpmedpub.com Jaypee-Highlights Medical Publishers Inc City of Knowledge, Bld 237, Clayton Panama City, Panama Phone: + 507-301-0496 Fax: + 507-301-0499 Email: cservice@jphmedical.com Jaypee Medical Inc The Bourse 111 South Independence Mall East Suite 835, Philadelphia, PA 19106, USA Phone: + 267-519-9789 Email: joe.rusko@jaypeebrothers.com Jaypee Brothers Medical Publishers (P) Ltd 17/1-B Babar Road, Block-B, Shaymali Mohammadpur, Dhaka-1207 Bangladesh Mobile: +08801912003485 Email: jaypeedhaka@gmail.com Jaypee Brothers Medical Publishers (P) Ltd Shorakhute, Kathmandu Nepal Phone: +00977-9841528578 Email: jaypee.nepal@gmail.com Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2014, Jaypee Brothers Medical Publishers The views and opinions expressed in this book are solely those of the original contributor(s)/author(s) and not necessarily represent those of editor(s) of the book All rights reserved No part of this publication may be reproduced, stored or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission in writing of the publishers All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners The publisher is not associated with any product or vendor mentioned in this book Medical knowledge and practice change constantly This book is designed to provide accurate, authoritative information about the subject matter in question However, readers are advised to check the most current information available on procedures included and check information from the manufacturer of each product to be administered, to verify the recommended dose, formula, method and duration of administration, adverse effects and contraindications It is the responsibility of the practitioner to take all appropriate safety precautions Neither the publisher nor the author(s)/editor(s) assume any liability for any injury and/or damage to persons or property arising from or related to use of material in this book This book is sold on the understanding that the publisher is not engaged in providing professional medical services If such advice or services are required, the services of a competent medical professional should be sought Every effort has been made where necessary to contact holders of copyright to obtain permission to reproduce copyright material If any have been inadvertently overlooked, the publisher will be pleased to make the necessary arrangements at the first opportunity Inquiries for bulk sales may be solicited at: jaypee@jaypeebrothers.com Drug and Device Selection in Heart Failure First Edition:  2014 ISBN 978-93-5090-723-8 Printed at Dedications I will like to dedicate this book to my mother Paras Devi who has constantly taught me that faith and humility are essential components for a peaceful and harmonious life Prakash C Deedwania Dedicated to Pia, Nick, and Chris “Knowledge belongs to humanity, and thus science knows no country and is the torch that illuminates the world.” –Louis Pasteur Paul J Mather Contents Renewed Understanding of the Pathophysiology of Heart Failure Kanu Chatterjee New Diuretics in Heart Failure 10 Jagroop S Basraon, Prakash C Deedwania Guideline-Based Standard Therapy for Heart Failure: The Role of RAAS Blockers and Beta Blockers 25 Prakash C Deedwania, Enrique Carbajal Emerging Role of Aldosterone Receptor Blockers in Heart Failure 43 Manjunath C Harlapur, Prakash C Deedwania Inotropic Therapy for Heart Failure: Past, Present, and Future 56 Paul J Hauptman, Patrick McCann Hospitalization for Heart Failure: Pathophysiology, Classification, and Management Considerations 78 Muthiah Vaduganathan, Mihai Gheorghiade Traditional Mechanical Support 97 Raphael E Bonita, Kariann Abbate Percutaneous Mechanical Support 110 Raphael E Bonita, Kariann Abbate Cardiac Resynchronization Therapy 124 Toshima Okabe, Behzad B Pavri 10 Sudden Cardiac Death and Implantable Cardioverter-Defibrillator 156 Toshima Okabe, Behzad B Pavri 11 Atrial Arrhythmias in Heart Failure Sumeet K Chhabra, Daniel R Frisch 184 viii Drug and Device Selection in Heart Failure 12 Ventricular Tachyarrhythmias in Patients with Congestive 203 Heart Failure Andrew Yin, Reginald T Ho 13 Heart Transplantation 218 Gordon R Reeves, Paul J Mather 14 Heart Failure 237 Anne P Canny Index 247 Contributors Editor Prakash C Deedwania MD FACC FACP FASH FAHA Professor of Medicine and Chief, Division of Cardiology Department of Medicine Veterans Affairs Central California Health Care System University of California, San Francisco Fresno, CA, USA Paul J Mather MD FACC FACP Professor of Medicine Director, Advanced Heart Failure and Cardiac Transplant Center Jefferson Heart Institute, Jefferson Medical College, Thomas Jefferson University Philadelphia, PA, USA contributing Authors Kariann Abbate MD Cardiology Fellow Jefferson Heart Institute, Jefferson Medical College, Thomas Jefferson University Philadelphia, PA, USA Jagroop S Basraon DO Physician Cardiology Fellow University of California, San Francisco Fresno, CA, USA Raphael E Bonita MD ScM FACC Assistant Professor of Medicine Advanced Heart Failure and Cardiac Transplant Center Jefferson Heart Institute, Jefferson Medical College, Thomas Jefferson University Philadelphia, PA, USA Anne P Canny RN MSN Heart Failure Nurse Coordinator Jefferson Heart Institute, Jefferson Medical College, Thomas Jefferson University Philadelphia, PA, USA Enrique Carbajal MD Associate Clinical Professor of Medicine Division of Cardiology, Department of Medicine Veterans Affairs Central California x Drug and Device Selection in Heart Failure Health Care System University of California San Francisco, Fresno Medical Education Program Fresno, CA, USA Kanu Chatterjee MBBS FRCP (London) FRCP (Edin) FAHA FCCP FACC MACP Clinical Professor of Medicine Division of Cardiology The Carver College of Medicine University of Iowa Iowa City, Iowa, USA Emeritus Professor of Medicine University of California San Francisco California, USA Sumeet K Chhabra MD Cardiology Fellow Jefferson Heart Institute, Jefferson Medical College Thomas Jefferson University Philadelphia, PA, USA Daniel R Frisch MD Director, Atrial Fibrillation Program Assistant Professor of Medicine Jefferson Heart Institute, Jefferson Medical College Thomas Jefferson University Philadelphia, PA, USA Mihai Gheorghiade MD FACC Professor of Medicine and Surgery Director of Experimental Therapeutics Center for Cardiovascular Innovation Northwestern University Feinberg School of Medicine Chicago, IL, USA Manjunath C Harlapur MD Fellow, Division of Cardiology Department of Medicine University of California, San Francisco Fresno, CA, USA Paul J Hauptman MD Professor of Internal Medicine Saint Louis University Hospital Saint Louis University School of Medicine Saint Louis, MO, USA Reginald T Ho MD Associate Professor of Medicine Division of Cardiac Electrophysiology Jefferson Heart Institute, Jefferson Medical College, Thomas Jefferson University Philadelphia, PA, USA Patrick McCann MD Division of Cardioloy Department of Medicine Saint Louis University School of Medicine Saint Louis, MO, USA Toshimasa Okabe MD Cardiology Fellow Jefferson Heart Institute, Jefferson Medical College, Thomas Jefferson University Philadelphia, PA, USA Behzad B Pavri MD Associate Professor of Medicine Director, CCEP Fellowship Jefferson Heart Institute, Jefferson Medical College, Thomas Jefferson University Philadelphia, PA, USA ... metalloproteinases is increased in SHF The ratio of titin isoforms N2BA/N2B is increased in SHF Ch -1. indd 10 -09-2 013 15 :23: 51 Drug and Device Selection in Heart Failure Table Myocyte and myocardial... Frisch 18 4 viii Drug and Device Selection in Heart Failure 12 Ventricular Tachyarrhythmias in Patients with Congestive 203 Heart Failure Andrew Yin, Reginald T Ho 13 Heart Transplantation 218 ... 2007 ;13 :569-76 Ch -1. indd 10 -09-2 013 15 :23: 51 Chapter 1: Renewed Understanding of the Pathophysiology of Heart Failure 11 Handoko ML, van Heeerbook L, Bronzwaer JG, et al Does diastolic heart

Ngày đăng: 20/01/2020, 14:44

Nguồn tham khảo

Tài liệu tham khảo Loại Chi tiết
1. Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.JAMA. 2006;296(18):2217-26 Khác
2. Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209-16 Khác
3. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J.2006;27(22):2725-36 Khác
4. Tavazzi L, Maggioni AP, Lucci D, et al. Nationwide survey on acute heart failure in cardiology ward services in italy. Eur Heart J. 2006;27(10):1207-15 Khác
5. Zannad F, Mebazaa A, Juillière Y, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail. 2006;8(7):697-705 Khác
6. Konstam MA, Gheorghiade M, Burnett JC, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA.2007;297(12):1319-31 Khác
7. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53(7):557-73 Khác
8. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787-847 Khác
9. Gheorghiade M, Filippatos G, De Luca L, et al. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119(12 Suppl 1):S3-S10 Khác
10. Gheorghiade M, Pang PS, Ambrosy AP, et al. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev. 2012;17(3):485-509 Khác
11. Metra M, Gheorghiade M, Bonow RO, et al. Postdischarge assessment after a heart failure hospitalization: the next step forward. Circulation. 2010;122(18):1782-5 Khác
12. Adamson PB, Magalski A, Braunschweig F, et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003;41(4):565-71 Khác
13. Drazner MH, Rame JE, Stevenson LW, et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med.2001;345(8):574-81 Khác
14. Lucas C, Johnson W, Hamilton MA, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000;140(6):840-7 Khác
15. Blair JE, Khan S, Konstam MA, et al. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009;30(13):1666-73 Khác
16. Davila C, Reyentovich A, Katz SD. Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure. J Card Fail. 2011;17(12):1018-22 Khác
17. Testani JM, Chen J, McCauley BD, et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.Circulation. 2010;122(3):265-72 Khác
18. Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12(5):423-33 Khác
19. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992;20(7):1594-8 Khác
20. Sabbah HN, Rosman H, Kono T, et al. On the mechanism of functional mitral regurgitation. Am J Cardiol. 1993;72(14):1074-6 Khác

TỪ KHÓA LIÊN QUAN